BackPardes Biosciences Overview

Pardes Biosciences Total Liabilities

Track Pardes Biosciences's total liabilities ($1.9M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$1.93M
↓ 82.84% YoYΔ $-9.30M vs prior year quarter

Peer average

Loading

Pardes Biosciences Total Liabilities History

Loading

Pardes Biosciences vs. peers: Total Liabilities Comparison

Loading

Pardes Biosciences Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Pardes Biosciences (PRDS) FAQ

The latest total liabilities for PRDS is $1.9M as of June 2023. That compares with $11M in the prior-year period — down 82.8% year over year. Investors often review this figure alongside Pardes Biosciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, PRDS's total liabilities moved from $11M to $1.9M — a 82.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Pardes Biosciences's operating scale or balance-sheet position.

A total liabilities figure of $1.9M for PRDS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PRDS's total liabilities ($1.9M), review year-over-year change from $11M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.